DELRAY BEACH, Fla., May 16, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCBB:PSID), an emerging growth company and developer of advanced technologies for diabetes management as well as sophisticated airborne bio-threat detection systems for America’s homeland defense, today announced it has made significant progress in testing its M-BAND, Microfluidics-based Bioagent Autonomous Networked Detector, in preparation for the Department of Homeland Security’s $3 billion BioWatch procurement. The Company’s M-BAND system detects five organisms on the CDC Select Agents List, which is a requirement for BioWatch.
